UK markets closed

Asensus Surgical, Inc. (2TX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2060+0.0060 (+3.00%)
At close: 04:51PM CET
Full screen
Previous close0.2000
Open0.2040
Bid0.2100 x N/A
Ask0.2340 x N/A
Day's range0.2040 - 0.2060
52-week range0.1830 - 0.7100
Volume5,420
Avg. volume2,025
Market cap60.52M
Beta (5Y monthly)1.47
PE ratio (TTM)N/A
EPS (TTM)-0.2900
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • GlobeNewswire

    Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023

    RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced its operating and financial results for the fourth quarter and full year 2023. Full Year Highlights Completed in vivo evaluation of the LUNA™ Surgical System by nine independent surgeons through thirteen procedures across gynecology, urology, and general surgeryOver 3,550 surgical pr

  • GlobeNewswire

    Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024

    RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently

  • GlobeNewswire

    Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

    RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company’s virtual presentation will take place on Tuesday, March 12, 2024 at 4:40 pm Eastern Time. The conference webcast will be available online on the investor relations page of the Company’s website